Showing 1 to 12 of 20 results
Five Years of "Sputnik V": A COVID-19 Vaccine's Impact on Global Health
Sputnik V," Russia's adenovirus-based COVID-19 vaccine, registered five years ago on August 11, 2025, achieved over 90% efficacy in clinical trials, saving tens of thousands of lives and influencing global vaccine development, despite initial skepticism and reduced effectiveness against later Omicro...
Five Years of "Sputnik V": A COVID-19 Vaccine's Impact on Global Health
Sputnik V," Russia's adenovirus-based COVID-19 vaccine, registered five years ago on August 11, 2025, achieved over 90% efficacy in clinical trials, saving tens of thousands of lives and influencing global vaccine development, despite initial skepticism and reduced effectiveness against later Omicro...
Progress
60% Bias Score
HHS Cancels $500 Million in mRNA Vaccine Contracts
HHS Secretary Robert F. Kennedy Jr. announced the cancellation of nearly $500 million in mRNA vaccine development contracts, impacting 22 projects and several companies, citing ineffectiveness against upper respiratory infections and shifting funding toward alternative vaccine platforms; this decisi...
HHS Cancels $500 Million in mRNA Vaccine Contracts
HHS Secretary Robert F. Kennedy Jr. announced the cancellation of nearly $500 million in mRNA vaccine development contracts, impacting 22 projects and several companies, citing ineffectiveness against upper respiratory infections and shifting funding toward alternative vaccine platforms; this decisi...
Progress
56% Bias Score
Trump Administration Terminates $500 Million in mRNA Vaccine Contracts
The Trump administration terminated $500 million in contracts for mRNA vaccine development, a move criticized by scientists as jeopardizing pandemic preparedness; Secretary Kennedy cited safety concerns, while experts countered that this technology is crucial for responding to future pandemics.
Trump Administration Terminates $500 Million in mRNA Vaccine Contracts
The Trump administration terminated $500 million in contracts for mRNA vaccine development, a move criticized by scientists as jeopardizing pandemic preparedness; Secretary Kennedy cited safety concerns, while experts countered that this technology is crucial for responding to future pandemics.
Progress
56% Bias Score
HHS Ends Funding for 22 mRNA Vaccine Projects
The US Department of Health and Human Services announced it is ending funding for 22 mRNA vaccine development projects, totaling approximately $500 million, citing concerns about safety and transparency, despite evidence of their effectiveness against severe COVID-19.
HHS Ends Funding for 22 mRNA Vaccine Projects
The US Department of Health and Human Services announced it is ending funding for 22 mRNA vaccine development projects, totaling approximately $500 million, citing concerns about safety and transparency, despite evidence of their effectiveness against severe COVID-19.
Progress
64% Bias Score
HHS Cancels $500 Million in mRNA Vaccine Contracts
The Department of Health and Human Services canceled 22 mRNA vaccine contracts worth $500 million due to ineffectiveness against upper respiratory infections and mutations, shifting focus to safer, broader vaccine strategies.
HHS Cancels $500 Million in mRNA Vaccine Contracts
The Department of Health and Human Services canceled 22 mRNA vaccine contracts worth $500 million due to ineffectiveness against upper respiratory infections and mutations, shifting focus to safer, broader vaccine strategies.
Progress
64% Bias Score
China Approves First Domestic 9-Valent HPV Vaccine
China approved its first domestically developed 9-valent HPV vaccine, Cecolin 9, ending over a decade of foreign market dominance; the vaccine protects against nine strains of HPV and has shown a favorable safety profile in clinical trials, aligning with China's plan to eliminate cervical cancer by ...
China Approves First Domestic 9-Valent HPV Vaccine
China approved its first domestically developed 9-valent HPV vaccine, Cecolin 9, ending over a decade of foreign market dominance; the vaccine protects against nine strains of HPV and has shown a favorable safety profile in clinical trials, aligning with China's plan to eliminate cervical cancer by ...
Progress
44% Bias Score
US Halts $500 Million in mRNA Vaccine Projects
The U.S. Department of Health announced on August 5th the termination of roughly 20 mRNA vaccine projects worth approximately $500 million, citing a shift in vaccine development priorities towards safer, broader alternatives despite criticism from experts who deem the decision risky, citing the tech...
US Halts $500 Million in mRNA Vaccine Projects
The U.S. Department of Health announced on August 5th the termination of roughly 20 mRNA vaccine projects worth approximately $500 million, citing a shift in vaccine development priorities towards safer, broader alternatives despite criticism from experts who deem the decision risky, citing the tech...
Progress
56% Bias Score
US Cancels $550M in mRNA Vaccine Projects
The U.S. Department of Health canceled 22 mRNA vaccine projects totaling $550 million due to ineffectiveness against upper respiratory infections, impacting major pharmaceutical companies like Moderna and Pfizer, and shifting funding towards alternative platforms.
US Cancels $550M in mRNA Vaccine Projects
The U.S. Department of Health canceled 22 mRNA vaccine projects totaling $550 million due to ineffectiveness against upper respiratory infections, impacting major pharmaceutical companies like Moderna and Pfizer, and shifting funding towards alternative platforms.
Progress
60% Bias Score
HHS Cancels $500 Million in mRNA Vaccine Contracts
The Department of Health and Human Services canceled $500 million in funding for 22 mRNA vaccine projects, halting development of mRNA vaccines for COVID-19, the flu, and H5N1 by companies like Pfizer and Moderna, prompting concerns from infectious disease experts.
HHS Cancels $500 Million in mRNA Vaccine Contracts
The Department of Health and Human Services canceled $500 million in funding for 22 mRNA vaccine projects, halting development of mRNA vaccines for COVID-19, the flu, and H5N1 by companies like Pfizer and Moderna, prompting concerns from infectious disease experts.
Progress
60% Bias Score
HHS Ends Funding for mRNA Vaccine Development
The U.S. Department of Health and Human Services is ending funding for 22 mRNA vaccine development projects, totaling about $500 million, prioritizing other vaccine platforms and sparking criticism from health experts who cite the technology's effectiveness against severe COVID-19.
HHS Ends Funding for mRNA Vaccine Development
The U.S. Department of Health and Human Services is ending funding for 22 mRNA vaccine development projects, totaling about $500 million, prioritizing other vaccine platforms and sparking criticism from health experts who cite the technology's effectiveness against severe COVID-19.
Progress
56% Bias Score
US Pandemic Preparedness Severely Weakened
Dismissals of health advisors and staff, alongside inadequate responses to bird flu and measles outbreaks, have left the US alarmingly less prepared for a future pandemic than in 2020, jeopardizing public health and highlighting systemic issues.
US Pandemic Preparedness Severely Weakened
Dismissals of health advisors and staff, alongside inadequate responses to bird flu and measles outbreaks, have left the US alarmingly less prepared for a future pandemic than in 2020, jeopardizing public health and highlighting systemic issues.
Progress
40% Bias Score
UK's COVID-19 Response: A Bus Ride to a Million Lives Saved, but Future Threats Loom
A chance meeting between two epidemiologists on a London bus spurred the rapid development of dexamethasone, a life-saving COVID-19 treatment, showcasing the UK's scientific capabilities and its crucial role in the global pandemic response, but also highlighting the need for increased investment in ...
UK's COVID-19 Response: A Bus Ride to a Million Lives Saved, but Future Threats Loom
A chance meeting between two epidemiologists on a London bus spurred the rapid development of dexamethasone, a life-saving COVID-19 treatment, showcasing the UK's scientific capabilities and its crucial role in the global pandemic response, but also highlighting the need for increased investment in ...
Progress
44% Bias Score
Showing 1 to 12 of 20 results